临床案例 / 真实世界数据
吾谷灵：结肠癌复发患者案例
关键数据一览
208.5ng/mL
CEA 癌胚抗原
显著下降
血红蛋白 10.9→13.5 g/dL
+7磅
体重 108→115
增重改善
白细胞恢复正常
患者基本情况
患者女性，50岁，结肠癌复发，就医地点美国。自2024年4月开始服用吾谷灵五谷虫。
临床情况对比
| 指标 | 2024-04-12 | 2024-05-09 | 2024-06-04 | 备注 |
|---|---|---|---|---|
| 体重 | 108磅 | 113磅 | 115磅 | 增重明显 |
| 血红蛋白 | 10.9 g/dL（低） | 达标 | 达标 | 服药后改善 |
| 白细胞 | 6.23（正常） | 7.24（正常） | - | 无需升白针 |
| 精神状态 | 较差 | 明显改善 | 精神体力不错 | 改善明显 |
肿瘤标志物 CEA 对比
| 日期 | CEA（ng/mL） | 正常范围 |
|---|---|---|
| 2024-04-12 | 280.9 | 0.0-2.5 |
| 2024-05-09 | 256.9 | 0.0-2.5 |
| 2024-06-04 | 208.5 | 0.0-2.5 |
医学分析
CEA 从 280.9 降至 208.5 ng/mL，呈明显下降趋势，提示肿瘤活动减弱。体重与食欲回升，营养状况改善。血液指标血红蛋白达标、白细胞正常，不再需要升白针。吾谷灵通过抑制肿瘤细胞周期、防止转移、全程免疫支持三个层面发挥作用。
个案仅供参考，不构成医疗建议。
医学报告与数据
重要声明：本页面为吾谷灵™五谷虫真实世界辅助调理个案整理，仅供学术交流参考，不构成医疗建议，不能替代手术、放疗、化疗等标准抗肿瘤治疗。个案结果因人而异，具体用药请遵医嘱。
Clinical Cases / Real-world Data
Vogreen: Colon Cancer Recurrence Patient Case
Key Data Overview
208.5ng/mL
CEA (Carcinoembryonic Antigen)
Significantly decreased
Hemoglobin 10.9→13.5 g/dL
+7lbs
Weight 108→115
Weight gain improved
WBC normalized
Case Summary
A 50-year-old female with recurrent colon cancer (treated in the USA) began Vogreen Medicinal Housefly Larvae in April 2024. Over follow-up, weight rose from 108 to 115 lbs, hemoglobin normalized, WBC stayed normal without G-CSF, and CEA fell from 280.9 to 208.5 ng/mL, indicating weakened tumor activity. Vogreen acts via inhibiting tumor cell cycles, anti-metastasis and full-course immune support. For reference only, not medical advice.
Key Data & Reports
Please refer to the medical reports and data charts below for detailed examination results and imaging records.
Medical Reports & Data
Disclaimer: This page documents a real-world adjuvant care case of Vogreen Medicinal Housefly Larvae for academic exchange only. It does not constitute medical advice and cannot replace standard anti-tumor treatments such as surgery, radiotherapy or chemotherapy. Individual results vary. Please follow your physician's guidance.